Literature DB >> 16534433

Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.

Marvin S Swartz1, H Ryan Wagner, Jeffrey W Swanson, T Scott Stroup, Joseph P McEvoy, Jose M Canive, Del D Miller, Fred Reimherr, Mark McGee, Ahsan Khan, Richard Van Dorn, Robert A Rosenheck, Jeffrey A Lieberman.   

Abstract

This study examined baseline correlates of substance use in the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness project. Approximately 60% of the sample was found to use substances, including 37% with current evidence of substance use disorders. Users (with and without substance use disorders), compared with nonusers, were significantly more likely to be male, be African-American, have lower educational attainment, have a recent period of homelessness, report more childhood conduct problems, have a history of major depression, have lower negative symptom and higher positive symptom scores on the Positive and Negative Syndrome Scale, and have a recent illness exacerbation. Individuals with comorbid substance use disorders were significantly more likely to be male, report more childhood conduct problems, have higher positive symptom scores on the Positive and Negative Syndrome Scale, and have a recent illness exacerbation. These analyses suggest that substance use disorders in schizophrenia are especially common among men with a history of childhood conduct disorder problems and that childhood conduct disorder problems are potent risk factors for substance use disorders in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534433     DOI: 10.1097/01.nmd.0000202575.79453.6e

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  41 in total

Review 1.  Prevalence and impact of substance use among emerging adults with serious mental health conditions.

Authors:  Ashli J Sheidow; Michael McCart; Kristyn Zajac; Maryann Davis
Journal:  Psychiatr Rehabil J       Date:  2012

Review 2.  Substance abuse and schizophrenia: pharmacotherapeutic intervention.

Authors:  Alan I Green; Douglas L Noordsy; Mary F Brunette; Christopher O'Keefe
Journal:  J Subst Abuse Treat       Date:  2007-06-15

3.  Postmortem diagnosis and toxicological validation of illicit substance use.

Authors:  Elin Lehrmann; Zoan R Afanador; Amy Deep-Soboslay; Gloria Gallegos; William D Darwin; Ross H Lowe; Allan J Barnes; Marilyn A Huestis; Jean L Cadet; Mary M Herman; Thomas M Hyde; Joel E Kleinman; William J Freed
Journal:  Addict Biol       Date:  2008-01-14       Impact factor: 4.280

4.  Understanding associations between serious mental illness and hepatitis C virus among veterans: a national multivariate analysis.

Authors:  Seth Himelhoch; John F McCarthy; Dara Ganoczy; Deborah Medoff; Amy Kilbourne; Richard Goldberg; Lisa Dixon; Frederic C Blow
Journal:  Psychosomatics       Date:  2009 Jan-Feb       Impact factor: 2.386

Review 5.  Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.

Authors:  Giuseppe Carrà; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

6.  Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Schizophr Bull       Date:  2013-07-24       Impact factor: 9.306

7.  Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies.

Authors:  Pál Czobor; Richard A Van Dorn; Leslie Citrome; Rene S Kahn; W Wolfgang Fleischhacker; Jan Volavka
Journal:  Eur Neuropsychopharmacol       Date:  2015-04-30       Impact factor: 4.600

8.  The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC).

Authors:  Giuseppe Carrà; Sonia Johnson; Paul Bebbington; Matthias C Angermeyer; Dirk Heider; Traolach Brugha; Jean-Michel Azorin; Mondher Toumi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-17       Impact factor: 5.270

9.  Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.

Authors:  Matthew M Large; Glen Smith; Grant Sara; Michael B Paton; Karina Karolina Kedzior; Olav B Nielssen
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-27       Impact factor: 4.035

10.  Transcriptional correlates of human substance use.

Authors:  Elin Lehrmann; William J Freed
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.